PKD1L3
Polycystin-1-like protein 3
Also known as: PK1L3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z443
- Gene
- PKD1L3
- Ensembl
- ENSG00000277481
- Chromosome
- 16
- Canonical length
- 1732 aa
- Protein class
- Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a member of the polycystin protein family. The encoded protein contains 11 transmembrane domains, a latrophilin/CL-1-like GPCR proteolytic site (GPS) domain, and a polycystin-1, lipoxygenase, alpha-toxin (PLAT) domain. This protein may function as a component of cation channel pores.[provided by RefSeq, Apr 2009]
Canonical amino-acid sequenceUniProt
1732 residues, UniProt reviewed canonical sequence.
>Q7Z443|PKD1L3
1 MFFKGGSWLW LYIRTSIILG SELNSPAPHG QNNCYQLNRF QCSFEEAQHY CHVQRGFLAH
61 IWNKEVQDLI RDYLEEGKKW WIGQNVMPLK KHQDNKYPAD VAANGPPKPL SCTYLSRNFI
121 RISSKGDKCL LKYYFICQTG DFLDGDAHYE RNGNNSHLYQ RHKKTKRGVA IARDKMPPGP
181 GHLPTTCHYP LPAHLSKTLC HPISQFPSVL SSITSQVTSA ASEPSSQPLP VITQLTMPVS
241 VTHAGQSLAE TTSSPKEEGH PNTFTSYLQV SLQKASGQVI DEIAGNFSRA VHGLQALNKL
301 QEACEFLQKL TALTPRFSKP AQVNLINSLI YLSEELLRIP FQNNNSLGFK VPPTVCPFHS
361 LNNVTKAGEG SWLESKRHTE PVEDILEMSL VEFGNIGEAF LEQNQSPESS VTLTSANATL
421 LLSRQNISTL PLSSYTLGHP APVRLGFPSA LALKELLNKH PGVNVQITGL AFNPFKDLDN
481 RNIVGSIGSV LLSANRKLLQ VHDLMEDIEI MLWRNVSLET HPTSLNMSTH QLTITVNVTS
541 LEKSLIVSID PDSPLLMTLY LGFQYQPNCT HFHLNITLPK DKVWQKDEEY TWVLNPEHLQ
601 HGIGTYYITA VLSERQEGAQ QTPSLVSVIT AVTQCYYWEI HNQTWSSAGC QVGPQSTILR
661 TQCLCNHLTF FASDFFVVPR TVNVEDTIKL FLRVTNNPVG VSLLASLLGF YVITVVWARK
721 KDQADMQKVK VTVLADNDPS AQFHYLIQVY TGYRRSAATT AKVVITLYGS EGRSEPHHLC
781 DPQKTVFERG GLDVFLLTTW TSLGNLHSLR LWHDNSGVSP SWYVSQVIVC DMAVKRKWHF
841 LCNCWLAVDL GDCELDRVFI PVSKRELFSF RHLFSSMIVE KFTQDYLWLS IATRHPWNQF
901 TRVQRLSCCM TLLLCNMVIN VMFWKINSTT AKRDEQMRPF AVAWSELLVS IHTAVILFPI
961 NLVIGRLFPL IEPQETLPLF PPIQASCLSD ASVEPLSATM VVEELKETVR FLLRRNTYLL
1021 SKCEQPPWSS WDITKLVKLL SSLVSSHLEG QGCHQQGERH WARVVPENHH HFCCYLHRVL
1081 QRLKSHLGTL GLTQGHQSCD FLDAASQLQK LQELLETHIL PTEQEPSREV TSFAILSSEE
1141 GKKPISNGLS KWLTSVCWLL LGFTSLASAF FTALYSLELS KDQATSWMIS IILSVLQNIF
1201 ISQPVKVVFF TFLYSLMMSR MPRLNKENEQ QTKRILALLA KCSSSVPGSR DKNNPVYVAP
1261 AINSPTKHPE RTLKKKKLFK LTGDILVQIL FLTLLMTAIY SAKNSNRFYL HQAIWKTFSH
1321 QFSEIKLLQD FYPWANHILL PSLYGDYRGK NAVLEPSHCK CGVQLIFQIP RTKTYEKVDE
1381 GQLAFCDNGH TCGRPKSLFP GLHLRRFSYI CSPRPMVLIP TDELHERLTS KNENGFSYIM
1441 RGAFFTSLRL ESFTSLQMSK KGCVWSIISQ VIYYLLVCYY AFIQGCQLKQ QKWRFFTGKR
1501 NILDTSIILI SFILLGLDMK SISLHKKNMA RYRDDQDRFI SFYEAVKVNS AATHLVGFPV
1561 LLATVQLWNL LRHSPRLRVI SRTLSRAWDE VVGFLLIILI LLTGYAIAFN LLFGCSISDY
1621 RTFFSSAVTV VGLLMGISHQ EEVFALDPVL GTFLILTSVI LMVLVVINLF VSAILMAFGK
1681 ERKSLKKEAA LIDTLLQKLS NLLGISWPQK TSSEQAATTA VGSDTEVLDE LPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PKD1L3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 11
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 0.9 nTPM
Expression across tissuesHPA
Tissue
- liver: 0.9 nTPM
- pituitary gland: 0.3 nTPM
- small intestine: 0.3 nTPM
- testis: 0.3 nTPM
- heart muscle: 0.2 nTPM
- adipose tissue: 0.1 nTPM
Single-cell type
- oocytes: 180 nCPM
- epicardial cells: 98 nCPM
- paneth cells: 85 nCPM
- sertoli cells: 64 nCPM
- lactotrophs: 26 nCPM
- cardiomyocytes: 24 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 0.9 nTPM
- cerebral cortex: 0.9 nTPM
- pons: 0.7 nTPM
- white matter: 0.7 nTPM
- choroid plexus: 0.6 nTPM
- hippocampal formation: 0.6 nTPM
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium ion transmembrane transport
- cellular response to acidic pH
- detection of chemical stimulus involved in sensory perception of sour taste
- detection of mechanical stimulus
- monoatomic cation transmembrane transport
- monoatomic cation transport
- sensory perception of sour taste
Molecular functions
- calcium channel activity
- calcium-activated cation channel activity
- carbohydrate binding
- pH-gated monoatomic ion channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPS motif
- Polycystic kidney disease type 1 protein
- PLAT/LH2 domain
- C-type lectin-like
- Polycystin cation channel, PKD1/PKD2
- C-type lectin-like/link domain superfamily
- C-type lectin fold
- PLAT/LH2 domain superfamily
- Polycystin-1 like, PLAT/LH2 domain
- GAIN domain superfamily
- Polycystin
- GAIN, subdomain B
- Lectin C-type domain
- PLAT/LH2 domain
- GPCR proteolysis site, GPS, motif
- Polycystin cation channel
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PKD1L3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PKD1L3 as an antibody target. Whether an autoantibody or antibody against PKD1L3 could matter depends on whether native PKD1L3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PKD1L3 is annotated at the cell surface, where native PKD1L3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PKD1L3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...